NASDAQ:EPZM

About

Thing
Cofactor will automatically discover the description of this topic and display it here.

Pronunciation

English

NASDAQ:EPZM

NASDAQ:EPZM
SpellingNASDAQ:EPZM
Pronunciation[NASDAQ:EPZM]

Mentions

Epizyme, Inc. (Nasdaq: EPZM), a biopharmaceutical company developing novel epigenetic therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval of TAZVERIK™ (tazemetostat) for the treatment of adults and pediatric patients aged 16 years and older with metastatic or locally advanced epithelioid sarcoma not eligible for complete resection, based on overall response rate and duration of response in a Phase 2 clinical trial.

New to Cofactor?

Cofactor is a large, structured listing of people, places, and things. Here you can find the description of each topic.

See also: